| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/10253890400019672 |
| P698 | PubMed publication ID | 16019588 |
| P2093 | author name string | Broekkamp CL | |
| Peeters BW | |||
| Tonnaer JA | |||
| Schoonen WG | |||
| Gebhard R | |||
| Ruigt GS | |||
| van der Voort HA | |||
| Vanderheyden PM | |||
| Groen MB | |||
| Smets RJ | |||
| P2860 | cites work | Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor | Q22254872 |
| Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
| Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains | Q27757822 | ||
| Atomic structure of progesterone complexed with its receptor | Q27758487 | ||
| A nonsteroidal glucocorticoid receptor antagonist | Q44269097 | ||
| An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist | Q44489563 | ||
| Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue | Q44556209 | ||
| Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes | Q45007068 | ||
| Cellular uptake and transport of methylprednisolone at the blood-brain barrier. | Q45988131 | ||
| Multiple and cooperative trans-activation domains of the human glucocorticoid receptor | Q46099369 | ||
| An open label trial of C-1073 (mifepristone) for psychotic major depression | Q46152690 | ||
| Dexamethasone down-regulates endothelin receptors in human cerebromicrovascular endothelial cells | Q48158619 | ||
| Effects of the glucocorticoid antagonist RU 486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers: enhancement of plasma ACTH and cortisol secretion in underweight patients | Q48279043 | ||
| Structure-activity relationship and the mode of action of corticosteroid feedback on the secretion of corticotrophin-releasing factor (corticoliberin) | Q48351545 | ||
| Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation | Q48433814 | ||
| Increased urinary-free cortisol outputs in diabetic patients | Q48556277 | ||
| Beta-endorphin, adrenocorticotropic hormone and cortisol secretion in abstinent alcoholics. | Q48581246 | ||
| Urinary cortisol circadian rhythm in a group of high-functioning children with autism | Q50305446 | ||
| Increased urinary free cortisol: a potential intermediate phenotype of essential hypertension. | Q50908940 | ||
| Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients. | Q51015104 | ||
| Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. | Q53317895 | ||
| Synthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator-statin hybrids. | Q53637186 | ||
| Pituitary-adrenal response to the antiglucocorticoid action of RU 486 in Cushing's syndrome. | Q54284703 | ||
| The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 | ||
| The structure of the nuclear hormone receptors | Q28139668 | ||
| Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress | Q28207285 | ||
| Corticosteroids and cognition | Q28207453 | ||
| DST studies in psychotic depression: a meta-analysis | Q28253516 | ||
| The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response | Q28281893 | ||
| Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders | Q31811786 | ||
| Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy | Q31925061 | ||
| Diagnosis and complications of Cushing's syndrome: a consensus statement. | Q33974513 | ||
| Ocular complications of topical, peri-ocular, and systemic corticosteroids | Q34120572 | ||
| Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. | Q34347790 | ||
| Mifepristone: bioavailability, pharmacokinetics and use-effectiveness | Q34540819 | ||
| Osteoporosis in Cushing's syndrome | Q34562103 | ||
| Early pregnancy termination with mifepristone and misoprostol in the United States | Q34746967 | ||
| Corticosteroid-induced hypersensitivity reactions | Q35009163 | ||
| Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. | Q35054431 | ||
| Neuroendocrine aspects of hypercortisolism in major depression | Q35076825 | ||
| Glucocorticoids: new mechanisms and future agents | Q35093797 | ||
| Corticosteroids, stress, and aging | Q35237878 | ||
| Glucocorticoid-dependent hypertension | Q35358739 | ||
| The pursuit of differentiated ligands for the glucocorticoid receptor | Q35610713 | ||
| Do antidepressants regulate how cortisol affects the brain? | Q35641579 | ||
| Minireview: glucocorticoids--food intake, abdominal obesity, and wealthy nations in 2004. | Q35714898 | ||
| Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension | Q35806295 | ||
| Steroids and depression | Q36385553 | ||
| Characterization of human mineralocorticosteroid receptor expressed in the baculovirus system | Q37633253 | ||
| Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. | Q38536054 | ||
| A molecular framework for the actions of glucocorticoid hormones in the nervous system | Q38769006 | ||
| Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism | Q39115297 | ||
| Search for antiglucocorticoid activity in rat liver in vivo | Q39305537 | ||
| The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone | Q40697465 | ||
| Dose-response relationships of RU 486. | Q40851571 | ||
| RU486 in depression | Q41085460 | ||
| Affinity-labeling steroids as biologically active probes of antiglucocorticoid hormone action | Q41473696 | ||
| Antiglucocorticoids: in vivo assay and evaluation of cortexolone, progesterone, and 6-beta-bromoprogesterone | Q42240856 | ||
| Steroid inhibition of neural microvessel morphogenesis in vitro: receptor mediation and astroglial dependence | Q43670406 | ||
| Functional domains of the human glucocorticoid receptor | Q43734761 | ||
| Effect of cortexolone on the feedback action of dexamethasone | Q43766246 | ||
| P433 | issue | 4 | |
| P921 | main subject | cortisol | Q190875 |
| P304 | page(s) | 233-241 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Stress | Q7623430 |
| P1476 | title | Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion | |
| P478 | volume | 7 |
| Q37774374 | 17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review |
| Q39017834 | A mixed glucocorticoid/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats. |
| Q28383953 | Achieving Remission in Gulf War Illness: A Simulation-Based Approach to Treatment Design |
| Q35952259 | Acute oral administration of the novel, competitive and selective glucocorticoid receptor antagonist ORG 34517 reduces the severity of ethanol withdrawal and related hypothalamic-pituitary-adrenal axis activation |
| Q42073494 | An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics |
| Q34082581 | CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis |
| Q36033490 | Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats |
| Q46694906 | Corticosteroids mediate fast feedback of the rat hypothalamic-pituitary-adrenal axis via the mineralocorticoid receptor. |
| Q39749277 | Differential effect of glucocorticoid receptor antagonists on glucocorticoid receptor nuclear translocation and DNA binding. |
| Q33612299 | Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells |
| Q41924903 | Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal |
| Q40779121 | Glucocorticoids Suppress the Protective Effect of Cyclooxygenase-2-Related Signaling on Hippocampal Neurogenesis Under Acute Immune Stress |
| Q38183382 | Making memories of stressful events: a journey along epigenetic, gene transcription, and signaling pathways |
| Q37443907 | RU486 Mitigates Hippocampal Pathology Following Status Epilepticus |
| Q39960078 | The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner |
Search more.